Former pharmaceutical CEO Martin Shkreli was ordered to pay a $64.6 million fine and was banned from participating in the pharmaceutical industry “in any capacity” Friday.

The ruling from U.S. District Judge Denise Cote came in response to an antitrust suit filed against Shkreli, a 38-year-old often called “Pharma Bro.” In 2020, New York State Attorney General Letitia James filed a suit arguing he engaged in illegal monopolistic behavior to increase the price of anti-malarial drug Daraprim. The Federal Trade Commission and seven states joined the suit.